Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical ...

Overview: Dyadic International, Inc. is a biotechnology platform company that develops, produces, and sells enzymes and other proteins both in the United States and internationally, with a market ...

This webpage provides information about the research project “Methods for the Analysis of Longitudinal Dyadic Data, with Applications to Intergenerational Exchanges of Family Support”. The three-year ...

Dyadic International (DYAI) announced that it has been awarded a $3M grant from the Gates Foundation for the cell line development of monoclonal antibodies targeting respiratory syncytial virus ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Movement triggered a dramatic shift in Hong Kong's political landscape. In 2020, the Chinese central government enacted the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Primates have big brains, but so do elephants and whales. Elephants and whales, however, have much larger bodies that their ...

Dyadic International Inc (NASDAQ:DYAI) reported a significant increase in revenue for Q3 2024, reaching approximately $1,958,000 compared to $397,000 for the same period a year ago. The company has ...